<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38826995</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Multidisciplinary Management Strategies for Long COVID: A Narrative Review.</ArticleTitle><Pagination><StartPage>e59478</StartPage><MedlinePgn>e59478</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e59478</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.59478</ELocationID><Abstract><AbstractText>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused millions of infections to date and has led to a worldwide pandemic. Most patients had a complete recovery from the acute infection, however, a large number of the affected individuals experienced symptoms that persisted more than 3 months after diagnosis. These symptoms most commonly include fatigue, memory difficulties, brain fog, dyspnea, cough, and other less common ones such as headache, chest pain, paresthesias, mood changes, muscle pain, and weakness,&#xa0;skin rashes, and cardiac, endocrine, renal and hepatic manifestations. The treatment of this syndrome remains challenging. A multidisciplinary approach to address combinations of symptoms affecting multiple organ systems has been widely adopted. This narrative review aims to bridge the gap surrounding the broad treatment approaches by providing an overview of multidisciplinary management strategies&#xa0;for the most common long COVID conditions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024, Prusinski et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prusinski</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pain Medicine, Mayo Clinic, Jacksonville, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pain Medicine, Mayo Clinic, Jacksonville, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klasova</LastName><ForeName>Johana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pain Medicine, Mayo Clinic, Jacksonville, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McVeigh</LastName><ForeName>Kimberly H</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Department of Pain Medicine, Mayo Clinic, Jacksonville, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Sadia Z</ForeName><Initials>SZ</Initials><AffiliationInfo><Affiliation>Department of Transplantation, Mayo Clinic, Jacksonville, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fermo</LastName><ForeName>Olga P</ForeName><Initials>OP</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Jacksonville, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubrova</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farr</LastName><ForeName>Ellen M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Linus C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Pain Medicine, Mayo Clinic, Jacksonville, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Lahey Hospital &amp; Medical Center, Burlington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerardo-Manrique</LastName><ForeName>Gerardo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergquist</LastName><ForeName>Thomas F</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Psychology, Mayo Clinic, Rochester, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Si M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Mayo Clinic, Jacksonville, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engelberg-Cook</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pain Medicine, Mayo Clinic, Jacksonville, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hare</LastName><ForeName>Joshua M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Cardiovascular Division and the Interdisciplinary Stem Cell Institute, Miami, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>March</LastName><ForeName>Keith L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Center for Regenerative Medicine, University of Florida, Gainesville, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caplan</LastName><ForeName>Arnold I</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>Department of Biology, Case Western Reserve University School of Medicine, Cleveland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Wenchun</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Pain Medicine, Mayo Clinic, Jacksonville, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Regenerative Biotherapeutics, Mayo Clinic, Jacksonville, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">a multidisciplinary approach for long covid</Keyword><Keyword MajorTopicYN="N">a narrative review for long covid management</Keyword><Keyword MajorTopicYN="N">management strategies for long covid</Keyword><Keyword MajorTopicYN="N">post-acute sequelae sars-cov-2 infection</Keyword><Keyword MajorTopicYN="N">severe acute respiratory syndrome coronavirus 2</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>3</Day><Hour>4</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38826995</ArticleId><ArticleId IdType="pmc">PMC11142761</ArticleId><ArticleId IdType="doi">10.7759/cureus.59478</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Organization WH. Number of COVID-19 cases reported to WHO.  [
Apr;
2024 
]. 2024. https://data.who.int/dashboards/covid19/cases?n=c https://data.who.int/dashboards/covid19/cases?n=c</Citation></Reference><Reference><Citation>Chronic COVID syndrome: need for an appropriate medical terminology for long-COVID and COVID long-haulers. Baig AM. J Med Virol. 2021;93:2555&#x2013;2556.</Citation><ArticleIdList><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>How and why patients made long COVID. Callard F, Perego E. Soc Sci Med. 2021;268:113426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19) van Kampen JJ, van de Vijver DA, Fraaij PL, et al. Nat Commun. 2021;12:267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7801729</ArticleId><ArticleId IdType="pubmed">33431879</ArticleId></ArticleIdList></Reference><Reference><Citation>A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection. Illness beyond acute infection and public health implications. Datta SD, Talwar A, Lee JT. JAMA. 2020;324:2251&#x2013;2252.</Citation><ArticleIdList><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Chippa V, Aleem A, Anjum F. StatPearls Publishing (FL): StatPearls [Internet]; 2023. Post-Acute Coronavirus (COVID-19) Syndrome.</Citation><ArticleIdList><ArticleId IdType="pubmed">34033370</ArticleId></ArticleIdList></Reference><Reference><Citation>A clinical case definition of post-COVID-19 condition by a Delphi consensus. Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. Lancet Infect Dis. 2022;22:0&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-acute sequelae of COVID-19 and the mental health implications. Walia N, Lat JO, Tariq R, et al.  https://discoveriesjournals.org/discoveries/D.2021.04.RA-Namrata.pdf Discoveries (Craiova) 2021;9:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8959835</ArticleId><ArticleId IdType="pubmed">35359346</ArticleId></ArticleIdList></Reference><Reference><Citation>Frequency, signs and symptoms, and criteria adopted for long COVID-19: a systematic review. Cabrera Martimbianco AL, Pacheco RL, Bagattini &#xc2;M, Riera R. Int J Clin Pract. 2021;75:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Historical Insight into infections and disorders associated with neurological and psychiatric sequelae similar to long COVID. Stefano GB. Med Sci Monit. 2021;27:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7924007</ArticleId><ArticleId IdType="pubmed">33633106</ArticleId></ArticleIdList></Reference><Reference><Citation>Long-term symptoms among adults tested for SARS-CoV-2 - United States, January 2020-April 2021. Wanga V, Chevinsky JR, Dimitrov LV, et al. MMWR Morb Mortal Wkly Rep. 2021;70:1235&#x2013;1241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8437054</ArticleId><ArticleId IdType="pubmed">34499626</ArticleId></ArticleIdList></Reference><Reference><Citation>The prevalence and long-term health effects of long COVID among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. O'Mahoney LL, Routen A, Gillies C, et al. EClinicalMedicine. 2023;55:101762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Global prevalence of post-Coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. J Infect Dis. 2022;226:1593&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Persistent SARS-2 infections contribute to long COVID-19. Jacobs JJ. Med Hypotheses. 2021;149:110538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7884250</ArticleId><ArticleId IdType="pubmed">33621843</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathological sequelae of long-haul COVID. Mehandru S, Merad M. Nat Immunol. 2022;23:194&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection. Ng OW, Chia A, Tan AT, Jadi RS, Leong HN, Bertoletti A, Tan YJ. Vaccine. 2016;34:2008&#x2013;2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7115611</ArticleId><ArticleId IdType="pubmed">26954467</ArticleId></ArticleIdList></Reference><Reference><Citation>Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection. Files JK, Boppana S, Perez MD, et al. J Clin Invest. 2021;131:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7773371</ArticleId><ArticleId IdType="pubmed">33119547</ArticleId></ArticleIdList></Reference><Reference><Citation>Multiple early factors anticipate post-acute COVID-19 sequelae. Su Y, Yuan D, Chen DG, et al. Cell. 2022;185:881&#x2013;895.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Viral persistence, reactivation, and mechanisms of long COVID. Chen B, Julg B, Mohandas S, Bradfute SB. Elife. 2023;12:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>Persistent lung injury and prothrombotic state in long COVID. Xiang M, Jing H, Wang C, Novakovic VA, Shi J. Front Immunol. 2022;13:862522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9021447</ArticleId><ArticleId IdType="pubmed">35464473</ArticleId></ArticleIdList></Reference><Reference><Citation>Stressful beginnings with long-term consequences. Consiglio CR, Brodin P. Cell. 2020;180:820&#x2013;821.</Citation><ArticleIdList><ArticleId IdType="pubmed">32142672</ArticleId></ArticleIdList></Reference><Reference><Citation>Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C) Gruber CN, Patel RS, Trachtman R, et al. Cell. 2020;183:982&#x2013;995.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489877</ArticleId><ArticleId IdType="pubmed">32991843</ArticleId></ArticleIdList></Reference><Reference><Citation>Unexplained post-acute infection syndromes. Choutka J, Jansari V, Hornig M, Iwasaki A. Nat Med. 2022;28:911&#x2013;923.</Citation><ArticleIdList><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, Lim PB. Clin Med (Lond) 2021;21:0&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical characterization of dysautonomia in long COVID-19 patients. Barizien N, Le Guen M, Russel S, Touche P, Huang F, Vall&#xe9;e A. Sci Rep. 2021;11:14042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8263555</ArticleId><ArticleId IdType="pubmed">34234251</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID or Post-COVID conditions.  [
Apr;
2024 
]. 2024. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html</Citation></Reference><Reference><Citation>Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms. Song E, Bartley CM, Chow RD, et al. Cell Rep Med. 2021;2:100288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8091032</ArticleId><ArticleId IdType="pubmed">33969321</ArticleId></ArticleIdList></Reference><Reference><Citation>Spectrum of respiratory involvement in COVID 19 era: an overview. Jain A, Talwar D, Kumar S. https://medicopublication.com/index.php/ijfmt/article/view/12644 Indian J Forensic Med Toxicol. 2020;14:6593&#x2013;6599.</Citation></Reference><Reference><Citation>Systematic review of changes and recovery in physical function and fitness after severe acute respiratory syndrome-related Coronavirus infection: implications for COVID-19 rehabilitation. Rooney S, Webster A, Paul L. Phys Ther. 2020;100:1717&#x2013;1729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454932</ArticleId><ArticleId IdType="pubmed">32737507</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Cares-Marambio K, Montenegro-Jim&#xe9;nez Y, Torres-Castro R, et al. Chron Respir Dis. 2021;18:14799731211002240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7975482</ArticleId><ArticleId IdType="pubmed">33729021</ArticleId></ArticleIdList></Reference><Reference><Citation>6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Huang C, Huang L, Wang Y, et al. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Quantitative chest CT assessment of small airways disease in post-acute SARS-CoV-2 infection. Cho JL, Villacreses R, Nagpal P, et al. Radiology. 2022;304:185&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9270680</ArticleId><ArticleId IdType="pubmed">35289657</ArticleId></ArticleIdList></Reference><Reference><Citation>Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection. Mylvaganam RJ, Bailey JI, Sznajder JI, Sala MA. Eur Respir Rev. 2021;30</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8674935</ArticleId><ArticleId IdType="pubmed">34911696</ArticleId></ArticleIdList></Reference><Reference><Citation>Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, Kell DB. Cardiovasc Diabetol. 2021;20:172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Respiratory follow-up of patients with COVID-19 pneumonia. George PM, Barratt SL, Condliffe R, et al. Thorax. 2020;75:1009&#x2013;1016.</Citation><ArticleIdList><ArticleId IdType="pubmed">32839287</ArticleId></ArticleIdList></Reference><Reference><Citation>Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Singh I, Joseph P, Heerdt PM, et al. Chest. 2022;161:54&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation. Maniscalco M, Ambrosino P, Fuschillo S, Stufano S, Sanduzzi A, Matera MG, Cazzola M. Respir Med. 2021;182:106401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8041746</ArticleId><ArticleId IdType="pubmed">33873099</ArticleId></ArticleIdList></Reference><Reference><Citation>Treatment of COVID-19-exacerbated asthma: should systemic corticosteroids be used? Kumar K, Hinks TS, Singanayagam A. Am J Physiol Lung Cell Mol Physiol. 2020;318:0&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7276980</ArticleId><ArticleId IdType="pubmed">32401670</ArticleId></ArticleIdList></Reference><Reference><Citation>Swiss recommendations for the follow-up and treatment of pulmonary long COVID. Funke-Chambour M, Bridevaux PO, Clarenbach CF, Soccal PM, Nicod LP, von Garnier C. Respiration. 2021;100:826&#x2013;841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339046</ArticleId><ArticleId IdType="pubmed">34091456</ArticleId></ArticleIdList></Reference><Reference><Citation>Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment. Myall KJ, Mukherjee B, Castanheira AM, et al. Ann Am Thorac Soc. 2021;18:799&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8086530</ArticleId><ArticleId IdType="pubmed">33433263</ArticleId></ArticleIdList></Reference><Reference><Citation>High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial) Dhooria S, Chaudhary S, Sehgal IS, et al. Eur Respir J. 2022;59</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8850687</ArticleId><ArticleId IdType="pubmed">34887325</ArticleId></ArticleIdList></Reference><Reference><Citation>Health-related quality of life in persons post-COVID-19 infection in comparison to normative controls and chronic pain patients. Moens M, Duarte RV, De Smedt A, et al. Front Public Health. 2022;10:991572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9632164</ArticleId><ArticleId IdType="pubmed">36339175</ArticleId></ArticleIdList></Reference><Reference><Citation>Lung fibrosis after COVID-19: treatment prospects. Bazdyrev E, Rusina P, Panova M, Novikov F, Grishagin I, Nebolsin V. Pharmaceuticals (Basel) 2021;14:807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8398080</ArticleId><ArticleId IdType="pubmed">34451904</ArticleId></ArticleIdList></Reference><Reference><Citation>Lung transplantation for post-COVID-19 pulmonary fibrosis. Gogia P, Attawar S, Singh V, Bhatnagar T, Sharma S, Batra K, Khare S. Respirol Case Rep. 2021;9:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8524671</ArticleId><ArticleId IdType="pubmed">34707876</ArticleId></ArticleIdList></Reference><Reference><Citation>Immuno-fibrotic drivers of impaired lung function in post-acute sequelae of SARS-CoV-2 infection (PASC) Chun HJ, Coutavas E, Pine A, et al. medRxiv. 2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8410030</ArticleId><ArticleId IdType="pubmed">34111030</ArticleId></ArticleIdList></Reference><Reference><Citation>1-year outcomes of lung transplantation for Coronavirus disease 2019-associated end-stage lung disease in the United States. Okumura K, Jyothula S, Kaleekal T, Dhand A. Clin Infect Dis. 2023;76:2140&#x2013;2147.</Citation><ArticleIdList><ArticleId IdType="pubmed">36757715</ArticleId></ArticleIdList></Reference><Reference><Citation>Evolution of echocardiographic abnormalities identified in previously healthy individuals recovering from COVID-19. Tudoran C, Tudoran M, Cut TG, et al. J Pers Med. 2022;12:46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8778114</ArticleId><ArticleId IdType="pubmed">35055360</ArticleId></ArticleIdList></Reference><Reference><Citation>Recovery of cardiac function following COVID-19&#xa0;-&#xa0;ECHOVID-19: a prospective longitudinal cohort study. Lassen MC, Skaarup KG, Lind JN, et al. Eur J Heart Fail. 2021;23:1903&#x2013;1912.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8652600</ArticleId><ArticleId IdType="pubmed">34514713</ArticleId></ArticleIdList></Reference><Reference><Citation>Systematic review of the prevalence of long COVID. Woodrow M, Carey C, Ziauddeen N, et al. Open Forum Infect Dis. 2023;10:233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10316694</ArticleId><ArticleId IdType="pubmed">37404951</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence and correlates of long COVID symptoms among US adults. Perlis RH, Santillana M, Ognyanova K, et al. JAMA Netw Open. 2022;5:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Alkodaymi MS, Omrani OA, Fawzy NA, et al. Clin Microbiol Infect. 2022;28:657&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiovascular abnormalities and mental health difficulties result in a reduced quality of life in the post-acute COVID-19 syndrome. Giurgi-Oncu C, Tudoran C, Pop GN, Bredicean C, Pescariu SA, Giurgiuca A, Tudoran M. Brain Sci. 2021;11:1456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8615893</ArticleId><ArticleId IdType="pubmed">34827455</ArticleId></ArticleIdList></Reference><Reference><Citation>Symptom persistence despite improvement in cardiopulmonary health - insights from longitudinal CMR, CPET and lung function testing post-COVID-19. Cassar MP, Tunnicliffe EM, Petousi N, et al. EClinicalMedicine. 2021;41:101159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8527025</ArticleId><ArticleId IdType="pubmed">34693230</ArticleId></ArticleIdList></Reference><Reference><Citation>2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play: a report of the American College of Cardiology Solution Set Oversight Committee. Gluckman TJ, Bhave NM, Allen LA, et al. J Am Coll Cardiol. 2022;79:1717&#x2013;1756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8926109</ArticleId><ArticleId IdType="pubmed">35307156</ArticleId></ArticleIdList></Reference><Reference><Citation>Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. Shi S, Qin M, Shen B, et al. JAMA Cardiol. 2020;5:802&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Special article - acute myocardial injury in patients hospitalized with COVID-19 infection: a review. Bavishi C, Bonow RO, Trivedi V, Abbott JD, Messerli FH, Bhatt DL. Prog Cardiovasc Dis. 2020;63:682&#x2013;689.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7274977</ArticleId><ArticleId IdType="pubmed">32512122</ArticleId></ArticleIdList></Reference><Reference><Citation>Prospective case-control study of cardiovascular abnormalities 6&#xa0;months&#xa0;following mild COVID-19 in&#xa0;healthcare workers. Joy G, Artico J, Kurdi H, et al. JACC Cardiovasc Imaging. 2021;14:2155&#x2013;2166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8105493</ArticleId><ArticleId IdType="pubmed">33975819</ArticleId></ArticleIdList></Reference><Reference><Citation>Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Halushka MK, Vander Heide RS. Cardiovasc Pathol. 2021;50:107300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7583586</ArticleId><ArticleId IdType="pubmed">33132119</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Kotecha T, Knight DS, Razvi Y, et al. Eur Heart J. 2021;42:1866&#x2013;1878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of breathing discomfort and respiratory sequelae in patients with post-acute sequelae of SARS-CoV-2 infection (PASC) Maley JH, Alba GA, Barry JT, et al. PM R. 2022;14:77&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">34902224</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID-19: a primer for cardiovascular health professionals, on behalf of the CCS Rapid Response Team. Paterson I, Ramanathan K, Aurora R, et al. Can J Cardiol. 2021;37:1260&#x2013;1262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180343</ArticleId><ArticleId IdType="pubmed">34090980</ArticleId></ArticleIdList></Reference><Reference><Citation>Long-COVID postural tachycardia syndrome: an American Autonomic Society statement. Raj SR, Arnold AC, Barboi A, et al. Clin Auton Res. 2021;31:365&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7976723</ArticleId><ArticleId IdType="pubmed">33740207</ArticleId></ArticleIdList></Reference><Reference><Citation>Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Blitshteyn S, Whitelaw S. Immunol Res. 2021;69:205&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009458</ArticleId><ArticleId IdType="pubmed">33786700</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine. O'Sullivan JS, Lyne A, Vaughan CJ. BMJ Case Rep. 2021;14:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8204164</ArticleId><ArticleId IdType="pubmed">34127505</ArticleId></ArticleIdList></Reference><Reference><Citation>Long-haul post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience. Johansson M, St&#xe5;hlberg M, Runold M, et al. JACC Case Rep. 2021;3:573&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7946344</ArticleId><ArticleId IdType="pubmed">33723532</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2018;Ivabradin&#x2019; versus &#x2018;Carvedilol&#x2019; in the management of Post-COVID-19 palpitation with sinus tachycardia. Jadhav K, Jariwala P. Indian Heart J. 2020;72:0.</Citation></Reference><Reference><Citation>A case report of postural tachycardia syndrome after COVID-19. Miglis MG, Prieto T, Shaik R, Muppidi S, Sinn DI, Jaradeh S. Clin Auton Res. 2020;30:449&#x2013;451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471493</ArticleId><ArticleId IdType="pubmed">32880754</ArticleId></ArticleIdList></Reference><Reference><Citation>What are the recommendations for returning athletes who have experienced long term COVID-19 symptoms? Lindsay RK, Wilson JJ, Trott M, et al. Ann Med. 2021;53:1935&#x2013;1944.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8567919</ArticleId><ArticleId IdType="pubmed">34726085</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-COVID-19 syndrome (long haul syndrome): description of a multidisciplinary clinic at Mayo Clinic and characteristics of the initial patient cohort. Vanichkachorn G, Newcomb R, Cowl CT, et al. Mayo Clin Proc. 2021;96:1782&#x2013;1791.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8112396</ArticleId><ArticleId IdType="pubmed">34218857</ArticleId></ArticleIdList></Reference><Reference><Citation>Virtual issue: COVID-19 and headache. Caronna E, Pozo-Rosich P. Headache. 2023;63:183&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pubmed">36633206</ArticleId></ArticleIdList></Reference><Reference><Citation>Phenotype-driven preventive strategies for migraine and other headaches. Wheeler SD. Neurologist. 2009;15:59&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">19276783</ArticleId></ArticleIdList></Reference><Reference><Citation>New daily persistent headache: a diagnostic and therapeutic odyssey. Riddle EJ, Smith JH. Curr Neurol Neurosci Rep. 2019;19:21.</Citation><ArticleIdList><ArticleId IdType="pubmed">30888529</ArticleId></ArticleIdList></Reference><Reference><Citation>Daily persistent headache after a viral illness during a worldwide pandemic may not be a new occurrence: Lessons from the 1890 Russian/Asiatic flu. Rozen TD. Cephalalgia. 2020;40:1406&#x2013;1409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7645599</ArticleId><ArticleId IdType="pubmed">33146034</ArticleId></ArticleIdList></Reference><Reference><Citation>Tension-type headache. Kaniecki RG. Continuum (Minneap Minn) 2012;18:823&#x2013;834.</Citation><ArticleIdList><ArticleId IdType="pubmed">22868544</ArticleId></ArticleIdList></Reference><Reference><Citation>Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E. Neurology. 2012;78:1337&#x2013;1345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3335452</ArticleId><ArticleId IdType="pubmed">22529202</ArticleId></ArticleIdList></Reference><Reference><Citation>The American Headache Society Consensus Statement: update on integrating new migraine treatments into clinical practice. Ailani J, Burch RC, Robbins MS. Headache. 2021;61:1021&#x2013;1039.</Citation><ArticleIdList><ArticleId IdType="pubmed">34160823</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacing as a treatment modality in migraine and tension-type headache. McLean A, Coutts K, Becker WJ. Disabil Rehabil. 2012;34:611&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pubmed">21980991</ArticleId></ArticleIdList></Reference><Reference><Citation>MRI negative myelopathy post mild SARS-CoV-2 infection: vasculopathy or inflammatory myelitis? Abrams RM, Safavi F, Tuhrim S, Navis A, Steinberger J, Shin SC. J Neurovirol. 2021;27:650&#x2013;655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8186350</ArticleId><ArticleId IdType="pubmed">34101085</ArticleId></ArticleIdList></Reference><Reference><Citation>Critical illness neuropathy in severe COVID-19: a case series. Bocci T, Campiglio L, Zardoni M, et al. Neurol Sci. 2021;42:4893&#x2013;4898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8414960</ArticleId><ArticleId IdType="pubmed">34477990</ArticleId></ArticleIdList></Reference><Reference><Citation>Peripheral neuropathy evaluations of patients with prolonged long COVID. Oaklander AL, Mills AJ, Kelley M, Toran LS, Smith B, Dalakas MC, Nath A. Neurol Neuroimmunol Neuroinflamm. 2022;9:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Small fiber neuropathy associated with SARS-CoV-2 infection. Abrams RM, Simpson DM, Navis A, Jette N, Zhou L, Shin SC. Muscle Nerve. 2022;65:440&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661991</ArticleId><ArticleId IdType="pubmed">34766365</ArticleId></ArticleIdList></Reference><Reference><Citation>Inflammatory olfactory neuropathy in two patients with COVID-19. Kirschenbaum D, Imbach LL, Ulrich S, et al. Lancet. 2020;396:166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7351381</ArticleId><ArticleId IdType="pubmed">32659210</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 associated cranial nerve neuropathy: a systematic review. Finsterer J, Scorza FA, Scorza C, Fiorini A. Bosn J Basic Med Sci. 2022;22:39&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8860318</ArticleId><ArticleId IdType="pubmed">34392827</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-acute sensory neurological sequelae in patients with severe acute respiratory syndrome coronavirus 2 infection: the COVID-PN observational cohort study. Odozor CU, Kannampallil T, Ben Abdallah A, et al. Pain. 2022;163:2398&#x2013;2410.</Citation><ArticleIdList><ArticleId IdType="pubmed">35324536</ArticleId></ArticleIdList></Reference><Reference><Citation>Critical illness myopathy as a consequence of COVID-19 infection. Tankisi H, Tankisi A, Harbo T, Markvardsen LK, Andersen H, Pedersen TH. Clin Neurophysiol. 2020;131:1931&#x2013;1932.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834604</ArticleId><ArticleId IdType="pubmed">32619798</ArticleId></ArticleIdList></Reference><Reference><Citation>Survivorship after COVID-19 ICU stay. Hosey MM, Needham DM. Nat Rev Dis Primers. 2020;6:60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7362322</ArticleId><ArticleId IdType="pubmed">32669623</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Katsoularis I, Fonseca-Rodr&#xed;guez O, Farrington P, Lindmark K, Fors Connolly AM. Lancet. 2021;398:599&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8321431</ArticleId><ArticleId IdType="pubmed">34332652</ArticleId></ArticleIdList></Reference><Reference><Citation>High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Helms J, Tacquard C, Severac F, et al. Intensive Care Med. 2020;46:1089&#x2013;1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197634</ArticleId><ArticleId IdType="pubmed">32367170</ArticleId></ArticleIdList></Reference><Reference><Citation>Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum. Barnes GD, Burnett A, Allen A, et al. J Thromb Thrombolysis. 2022;54:197&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9111941</ArticleId><ArticleId IdType="pubmed">35579732</ArticleId></ArticleIdList></Reference><Reference><Citation>Final Coronavirus disease (COVID-19) treatment guidelines (February 29, 2024)  [
Apr;
2024 
];https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf Coronavirus Disease. 2024 19:2023.</Citation></Reference><Reference><Citation>Thromboembolic complications during and after hospitalization for COVID-19: incidence, risk factors and thromboprophylaxis. Tholin B, Fiskvik H, Tveita A, et al. Thrombosis Update. 2022;6:100096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8720677</ArticleId><ArticleId IdType="pubmed">38620916</ArticleId></ArticleIdList></Reference><Reference><Citation>Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry. Giannis D, Allen SL, Tsang J, et al. Blood. 2021;137:2838&#x2013;2847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8032474</ArticleId><ArticleId IdType="pubmed">33824972</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence of symptomatic, image-confirmed venous thromboembolism following hospitalization for COVID-19 with 90-day follow-up. Salisbury R, Iotchkova V, Jaafar S, et al. Blood Adv. 2020;4:6230&#x2013;6239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7757009</ArticleId><ArticleId IdType="pubmed">33351117</ArticleId></ArticleIdList></Reference><Reference><Citation>Postdischarge thrombosis and hemorrhage in patients with COVID-19. Patell R, Bogue T, Koshy A, et al. Blood. 2020;136:1342&#x2013;1346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7483433</ArticleId><ArticleId IdType="pubmed">32766883</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence of 30-day venous thromboembolism in adults tested for SARS-CoV-2 infection in an integrated health care system in Northern California. Roubinian NH, Dusendang JR, Mark DG, Vinson DR, Liu VX, Schmittdiel JA, Pai AP. JAMA Intern Med. 2021;181:997&#x2013;1000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8022258</ArticleId><ArticleId IdType="pubmed">33818615</ArticleId></ArticleIdList></Reference><Reference><Citation>Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge. von Meijenfeldt FA, Havervall S, Adelmeijer J, et al. Blood Adv. 2021;5:756&#x2013;759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857699</ArticleId><ArticleId IdType="pubmed">33560386</ArticleId></ArticleIdList></Reference><Reference><Citation>American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients. Cuker A, Tseng EK, Sch&#xfc;nemann HJ, et al. Blood Adv. 2022;6:4975&#x2013;4982.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9236618</ArticleId><ArticleId IdType="pubmed">35748885</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevention, diagnosis, and treatment of VTE in patients with Coronavirus disease 2019: CHEST Guideline and Expert Panel Report. Moores LK, Tritschler T, Brosnahan S, et al. Chest. 2020;158:1143&#x2013;1163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7265858</ArticleId><ArticleId IdType="pubmed">32502594</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. Bikdeli B, Madhavan MV, Jimenez D, et al. J Am Coll Cardiol. 2020;75:2950&#x2013;2973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164881</ArticleId><ArticleId IdType="pubmed">32311448</ArticleId></ArticleIdList></Reference><Reference><Citation>Belgian clinical guidance on anticoagulation management in hospitalised and ambulatory patients with COVID-19. Vanassche T, Orlando C, Vandenbosch K, et al. Acta Clin Belg. 2022;77:280&#x2013;285.</Citation><ArticleIdList><ArticleId IdType="pubmed">33012274</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial. Ramacciotti E, Barile Agati L, Calderaro D, et al. Lancet. 2022;399:50&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8673881</ArticleId><ArticleId IdType="pubmed">34921756</ArticleId></ArticleIdList></Reference><Reference><Citation>Venous thromboembolism in patients discharged after COVID-19 hospitalization. Engelen MM, Vandenbriele C, Balthazar T, et al. Semin Thromb Hemost. 2021;47:362&#x2013;371.</Citation><ArticleIdList><ArticleId IdType="pubmed">33893631</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with long COVID/post-acute sequelae of COVID-19 (PASC) Pretorius E, Venter C, Laubscher GJ, et al. Cardiovasc Diabetol. 2022;21:148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-acute COVID-19 syndrome. Nalbandian A, Sehgal K, Gupta A, et al. Nat Med. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleep disturbance severity and correlates in post-acute sequelae of COVID-19 (PASC) Pena-Orbea C, Lapin B, Li Y, Englund K, Heinzinger C, Foldvary-Schaefer N, Mehra R. J Gen Intern Med. 2023;38:2015&#x2013;2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10072019</ArticleId><ArticleId IdType="pubmed">37014604</ArticleId></ArticleIdList></Reference><Reference><Citation>Management of long-COVID-19 patients with sleep disorders: practical advice to general practitioners. Guezguez F, Romdhani M, Boutaleb-Joutei A, Chamari K, Ben Saad H. Libyan J Med. 2023;18:2182704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9970199</ArticleId><ArticleId IdType="pubmed">36842064</ArticleId></ArticleIdList></Reference><Reference><Citation>Antidepressants for insomnia in adults. Everitt H, Baldwin DS, Stuart B, et al. Cochrane Database Syst Rev. 2018;5:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6494576</ArticleId><ArticleId IdType="pubmed">29761479</ArticleId></ArticleIdList></Reference><Reference><Citation>Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study. Camargos EF, Louzada LL, Quintas JL, Naves JO, Louzada FM, N&#xf3;brega OT. Am J Geriatr Psychiatry. 2014;22:1565&#x2013;1574.</Citation><ArticleIdList><ArticleId IdType="pubmed">24495406</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensitivity of the Jamar Dynamometer in detecting submaximal grip effort. Ashford RF, Nagelburg S, Adkins R. J Hand Surg Am. May. 1996;21:402&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">8724469</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE advises against using graded exercise therapy for patients recovering from covid-19. Torjesen I. BMJ. 2020;370:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">32694164</ArticleId></ArticleIdList></Reference><Reference><Citation>Myalgic encephalomyelitis/chronic fatigue syndrome: essentials of diagnosis and management. Bateman L, Bested AC, Bonilla HF, et al. Mayo Clin Proc. 2021;96:2861&#x2013;2878.</Citation><ArticleIdList><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Heat and cold sensitivity in multiple sclerosis: a patient-centred perspective on triggers, symptoms, and thermal resilience practices. Christogianni A, O'Garro J, Bibb R, Filtness A, Filingeri D. Mult Scler Relat Disord. 2022;67:104075.</Citation><ArticleIdList><ArticleId IdType="pubmed">35963205</ArticleId></ArticleIdList></Reference><Reference><Citation>A systematic review of neuropsychological and psychiatric sequalae of COVID-19: implications for treatment. Vanderlind WM, Rabinovitz BB, Miao IY, et al. Curr Opin Psychiatry. 2021;34:420&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8183238</ArticleId><ArticleId IdType="pubmed">34016818</ArticleId></ArticleIdList></Reference><Reference><Citation>Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection (PASC) Fine JS, Ambrose AF, Didehbani N, et al. PM R. 2022;14:96&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">34902226</ArticleId></ArticleIdList></Reference><Reference><Citation>The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Nasreddine ZS, Phillips NA, B&#xe9;dirian V, et al. J Am Geriatr Soc. 2005;53:695&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Folstein MF, Folstein SE, McHugh PR. J Psychiatr Res. 1975;12:189&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>A short test of mental status: description and preliminary results. Kokmen E, Naessens JM, Offord KP. Mayo Clin Proc. 1987;62:281&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">3561043</ArticleId></ArticleIdList></Reference><Reference><Citation>Population-based norms for the Mini-Mental State Examination by age and educational level. Crum RM, Anthony JC, Bassett SS, Folstein MF. https://pubmed.ncbi.nlm.nih.gov/8479064/ JAMA. 1993;269:2386&#x2013;2391.</Citation><ArticleIdList><ArticleId IdType="pubmed">8479064</ArticleId></ArticleIdList></Reference><Reference><Citation>The short test of mental status. Correlations with standardized psychometric testing. Kokmen E, Smith GE, Petersen RC, Tangalos E, Ivnik RC. Arch Neurol. 1991;48:725&#x2013;728.</Citation><ArticleIdList><ArticleId IdType="pubmed">1859300</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychological assessment. Kapur N. J Neurol. 2005;252:1290&#x2013;1291.</Citation></Reference><Reference><Citation>Predictors of cognitive dysfunction one-year post COVID-19. Cavaco S, Sousa G, Gon&#xe7;alves A, et al. Neuropsychology. 2023;37:557&#x2013;567.</Citation><ArticleIdList><ArticleId IdType="pubmed">36603126</ArticleId></ArticleIdList></Reference><Reference><Citation>Evidence-based cognitive rehabilitation: systematic review of the literature from 2009 through 2014. Cicerone KD, Goldin Y, Ganci K, et al. Arch Phys Med Rehabil. 2019;100:1515&#x2013;1533.</Citation><ArticleIdList><ArticleId IdType="pubmed">30926291</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehabilitation of neuropsychiatric symptoms in patients with long COVID: position statement. Sacks-Zimmerman A, Bergquist TF, Farr EM, Cornwell MA, Kanellopoulos D. Arch Phys Med Rehabil. 2023;104:350&#x2013;354.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9581644</ArticleId><ArticleId IdType="pubmed">36272444</ArticleId></ArticleIdList></Reference><Reference><Citation>Walthers KZ, Zimmer J. 2020. The utility of smart home technology within occupational therapy practice; p. 454.</Citation></Reference><Reference><Citation>Meta-analysis of prevalence: the psychological sequelae among COVID-19 survivors. Khraisat B, Toubasi A, AlZoubi L, Al-Sayegh T, Mansour A. Int J Psychiatry Clin Pract. 2022;26:234&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pubmed">34709105</ArticleId></ArticleIdList></Reference><Reference><Citation>The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Deng J, Zhou F, Hou W, et al. Ann N Y Acad Sci. 2021;1486:90&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675607</ArticleId><ArticleId IdType="pubmed">33009668</ArticleId></ArticleIdList></Reference><Reference><Citation>Posttraumatic stress disorder in patients after severe COVID-19 infection. Janiri D, Carf&#xec; A, Kotzalidis GD, Bernabei R, Landi F, Sani G. JAMA Psychiatry. 2021;78:567&#x2013;569.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893542</ArticleId><ArticleId IdType="pubmed">33599709</ArticleId></ArticleIdList></Reference><Reference><Citation>Internet-delivered cognitive behaviour therapy for chronic health conditions: a systematic review and meta-analysis. Mehta S, Peynenburg VA, Hadjistavropoulos HD. J Behav Med. 2019;42:169&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">30387008</ArticleId></ArticleIdList></Reference><Reference><Citation>Cognitive behavioral principles in managing chronic disease. White CA. West J Med. 2001;175:338&#x2013;342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1071616</ArticleId><ArticleId IdType="pubmed">11694487</ArticleId></ArticleIdList></Reference><Reference><Citation>Single-session acceptance and commitment therapy (ACT) interventions for patients with chronic health conditions: a systematic review and meta-analysis. Dochat C, Wooldridge JS, Herbert MS, Lee MW, Afari N. J Contextual Behav Sci. 2021;20:52&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8045767</ArticleId><ArticleId IdType="pubmed">33868913</ArticleId></ArticleIdList></Reference><Reference><Citation>Technology-supported acceptance and commitment therapy for chronic health conditions: a systematic review and meta-analysis. Herbert MS, Dochat C, Wooldridge JS, et al. Behav Res Ther. 2022;148:103995.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8712459</ArticleId><ArticleId IdType="pubmed">34800873</ArticleId></ArticleIdList></Reference><Reference><Citation>Physical exercise for treatment of mood disorders: a critical review. Hearing CM, Chang WC, Szuhany KL, Deckersbach T, Nierenberg AA, Sylvia LG. Curr Behav Neurosci Rep. 2016;3:350&#x2013;359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5423723</ArticleId><ArticleId IdType="pubmed">28503402</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute aerobic exercise helps overcome emotion regulation deficits. Bernstein EE, McNally RJ. Cogn Emot. 2017;31:834&#x2013;843.</Citation><ArticleIdList><ArticleId IdType="pubmed">27043051</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia. Krystal AD, Thakur M, Roth T. Ann Clin Psychiatry. 2008;20:39&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">18297585</ArticleId></ArticleIdList></Reference><Reference><Citation>Musculoskeletal symptoms and relationship with laboratory findings in patients with COVID-19. Batur EB, Korez MK, Gezer IA, Levendoglu F, Ural O. Int J Clin Pract. 2021;75:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250333</ArticleId><ArticleId IdType="pubmed">33686741</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID from rheumatology perspective - a narrative review. Sapkota HR, Nune A. Clin Rheumatol. 2022;41:337&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8629735</ArticleId><ArticleId IdType="pubmed">34845562</ArticleId></ArticleIdList></Reference><Reference><Citation>Effect of neuromuscular electrical stimulation on the recovery of people with COVID-19 admitted to the intensive care unit: a narrative review. Burgess LC, Venugopalan L, Badger J, et al. J Rehabil Med. 2021;53:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8814855</ArticleId><ArticleId IdType="pubmed">33634830</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID and the role of physical activity: a qualitative study. Humphreys H, Kilby L, Kudiersky N, Copeland R. BMJ Open. 2021;11:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7948149</ArticleId><ArticleId IdType="pubmed">33692189</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of inflammatory heart disease among professional athletes with prior COVID-19 infection who received systematic return-to-play cardiac screening. Martinez MW, Tucker AM, Bloom OJ, et al. JAMA Cardiol. 2021;6:745&#x2013;752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7934073</ArticleId><ArticleId IdType="pubmed">33662103</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID: distinction between organ damage and deconditioning. Kersten J, Baumhardt M, Hartveg P, et al. J Clin Med. 2021;10:3782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8432179</ArticleId><ArticleId IdType="pubmed">34501230</ArticleId></ArticleIdList></Reference><Reference><Citation>Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: evidence of skeletal muscle histopathology. Hejb&#xf8;l EK, Harbo T, Agergaard J, et al. Eur J Neurol. 2022;29:2832&#x2013;2841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9348124</ArticleId><ArticleId IdType="pubmed">35661354</ArticleId></ArticleIdList></Reference><Reference><Citation>The role of acupuncture for long COVID: mechanisms and models. Williams JE, Moramarco J. Med Acupunct. 2022;34:159&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9248327</ArticleId><ArticleId IdType="pubmed">35832109</ArticleId></ArticleIdList></Reference><Reference><Citation>Reflections of a COVID-19 long hauler. Siegelman JN. JAMA. 2020;324:2031&#x2013;2032.</Citation><ArticleIdList><ArticleId IdType="pubmed">33175108</ArticleId></ArticleIdList></Reference><Reference><Citation>Aerobic exercise increases irisin serum levels and improves depression and fatigue in patients with relapsing remitting multiple sclerosis: a randomized controlled trial. Bilek F, Cetisli-Korkmaz N, Ercan Z, Deniz G, Demir CF. Mult Scler Relat Disord. 2022;61:103742.</Citation><ArticleIdList><ArticleId IdType="pubmed">35349884</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Natarajan A, Zlitni S, Brooks EF, et al. Med. 2022;3:371&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Huang L, Li X, Gu X, et al. Lancet Respir Med. 2022;10:863&#x2013;876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastrointestinal sequelae 90 days after discharge for COVID-19. Weng J, Li Y, Li J, et al. Lancet Gastroenterol Hepatol. 2021;6:344&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7943402</ArticleId><ArticleId IdType="pubmed">33711290</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence and risk factors for gastrointestinal symptoms after recovery from COVID-19. Blackett JW, Li J, Jodorkovsky D, Freedberg DE. Neurogastroenterol Motil. 2022;34:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8646904</ArticleId><ArticleId IdType="pubmed">34468069</ArticleId></ArticleIdList></Reference><Reference><Citation>Symptomatology and microbiology of the gastrointestinal tract in post-COVID conditions. Norouzi Masir M, Shirvaliloo M. JGH Open. 2022;6:667&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9538198</ArticleId><ArticleId IdType="pubmed">36247234</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagnostic, prognostic, and therapeutic roles of gut microbiota in COVID-19: a comprehensive systematic review. Farsi Y, Tahvildari A, Arbabi M, et al. Front Cell Infect Microbiol. 2022;12:804644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8930898</ArticleId><ArticleId IdType="pubmed">35310853</ArticleId></ArticleIdList></Reference><Reference><Citation>Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Liu Q, Mak JW, Su Q, et al. Gut. 2022;71:544&#x2013;552.</Citation><ArticleIdList><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>A randomized controlled trial of the efficacy of systemic enzymes and probiotics in the resolution of post-COVID fatigue. Rathi A, Jadhav SB, Shah N. Medicines (Basel) 2021;8:47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8472462</ArticleId><ArticleId IdType="pubmed">34564089</ArticleId></ArticleIdList></Reference><Reference><Citation>The prevalence of acute kidney injury in patients hospitalized with COVID-19 infection: a systematic review and meta-analysis. Silver SA, Beaubien-Souligny W, Shah PS, et al. Kidney Med. 2021;3:83&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7723763</ArticleId><ArticleId IdType="pubmed">33319190</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID and kidney disease. Yende S, Parikh CR. Nat Rev Nephrol. 2021;17:792&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8427150</ArticleId><ArticleId IdType="pubmed">34504319</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathology of COVID-19-associated acute kidney injury. Sharma P, Ng JH, Bijol V, Jhaveri KD, Wanchoo R. Clin Kidney J. 2021;14:0&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929005</ArticleId><ArticleId IdType="pubmed">33796284</ArticleId></ArticleIdList></Reference><Reference><Citation>Delayed care with harmful health consequences-reported experiences from national surveys during Coronavirus disease 2019. Findling MG, Blendon RJ, Benson JM. JAMA Health Forum. 2020;1:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">36218479</ArticleId></ArticleIdList></Reference><Reference><Citation>The vascular nature of lung-resident mesenchymal stem cells. Steens J, Klar L, Hansel C, et al. Stem Cells Transl Med. 2021;10:128&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7780817</ArticleId><ArticleId IdType="pubmed">32830458</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesenchymal stem cells: characteristics and clinical applications. Bobis S, Jarocha D, Majka M. https://pubmed.ncbi.nlm.nih.gov/17219716/ Folia Histochem Cytobiol. 2006;44:215&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pubmed">17219716</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunomodulation and regenerative capacity of MSCs for long-COVID. Loke XY, Imran SA, Tye GJ, Wan Kamarul Zaman WS, Nordin F. Int J Mol Sci. 2021;22:12421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8625432</ArticleId><ArticleId IdType="pubmed">34830303</ArticleId></ArticleIdList></Reference><Reference><Citation>Support for rehabilitation: self-management after COVID-19 related illness.  [
Apr;
2024 
]. 2024. https://cdn.who.int/media/docs/default-source/ageing/support-for-rehabilitation-self-management-after-covid-19-related-illness-engf5cec00b-350b-4eb0-bc24-0704df509ae1.pdf?sfvrsn=203566f0_1&amp;download=true https://cdn.who.int/media/docs/default-source/ageing/support-for-rehabilitation-self-management-after-covid-19-related-illness-engf5cec00b-350b-4eb0-bc24-0704df509ae1.pdf?sfvrsn=203566f0_1&amp;download=true</Citation></Reference><Reference><Citation>Rehabilitation in long COVID-19: A mini-review. Swarnakar R, Yadav SL. World J Methodol. 2022;12:235&#x2013;245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9350732</ArticleId><ArticleId IdType="pubmed">36159093</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehabilitation interventions for post-acute COVID-19 syndrome: a systematic review. Fugazzaro S, Contri A, Esseroukh O, et al. Int J Environ Res Public Health. 2022;19:5185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9104923</ArticleId><ArticleId IdType="pubmed">35564579</ArticleId></ArticleIdList></Reference><Reference><Citation>SARS-CoV-2 evolves increased infection elicited cell death and fusion in an immunosuppressed individual. Lustig G, Ganga Y, Rodel H, et al. medRxiv. 2022</Citation></Reference><Reference><Citation>Effect of covid-19 vaccination on long covid: systematic review. Byambasuren O, Stehlik P, Clark J, Alcorn K, Glasziou P. BMJ Med. 2023;2:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>